Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer’s disease

Author： Lumbreras M. Baamonde C. Martínez-Cué C. Lubec G. Cairns N. Sallés J. Dierssen M. Flórez J.

ISSN： 0939-4451

Source： Amino Acids, Vol.31, Iss.4, 2006-11, pp. : 449-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroendocrine-Specific Protein C, a Marker of Neuronal Differentiation, Is Reduced in Brain of Patients with Down Syndrome and Alzheimer's Disease

By Kim S.H. Yoo B.C. Broers J.L.V. Cairns N. Lubec G.

Biochemical and Biophysical Research Communications, Vol. 276, Iss. 1, 2000-09 ,pp. : 329-334

Elsevier

Access to resources Recommend Favorite

Hypoxia signaling to genes: Significance in Alzheimer’s disease

By Bazan Nicolas Palacios-Pelaez Ricardo Lukiw Walter

Molecular Neurobiology, Vol. 26, Iss. 2-3, 2002-10 ,pp. : 283-298

Humana Press, Inc

Access to resources Recommend Favorite

Sporadic Alzheimer’s Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer’s Disease Genes

By Pluta Ryszard Jabłoński Mirosław Ułamek-Kozioł Marzena Kocki Janusz Brzozowska Judyta Januszewski Sławomir Furmaga-Jabłońska Wanda Bogucka-Kocka Anna Maciejewski Ryszard Czuczwar Stanisław

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 500-515

Humana Press, Inc

Access to resources Recommend Favorite

Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy

By Zhihui Qin

Future Medicinal Chemistry, Vol. 5, Iss. 12, 2013-08 ,pp. : 1451-1468

Future Science

Access to resources Recommend Favorite

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome

By Hwan Kim S. Fountoulakis M. Cairns N.J. Lubec G.

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 4, 2002-08 ,pp. : 970-975

Elsevier

Access to resources Recommend Favorite